Topic Menu
► Topic MenuTopic Editors

2. Associate Laboratory i4HB - Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal
3. FP-I3ID (Instituto de Investigação, Inovação e Desenvolvimento), FP-BHS (Biomedical and Health Sciences Research Unit), Faculty of Health Sciences, University Fernando Pessoa, 4249-004 Porto, Portugal

2. Mesosystem Investigação & Investimentos by Spinpark, Barco, 4805-017 Guimarães, Portugal

2. Mesosystem Investigação & Investimentos by Spinpark, Barco, 4805-017 Guimarães, Portugal
New Challenges in the Cosmetics Industry
Topic Information
Dear Colleagues,
Currently, cosmetics and medical device manufacturers face several challenges in developing innovative products, with the main objective of meeting the different needs of consumers. In this context, the increasingly widespread use of natural compounds as a source of bioactive molecules, associated with the reuse of industrial and natural waste, in a circular economy perspective, brings economic, environmental and performance advantages to this new product. These bioactive molecules have been showing different activities, such as antioxidant, anti-inflammatory, and antimicrobial. In addition, the advent of the biotechnology industry has brought new ingredients, including growth factors, enzymes, peptides, and stem cells, among others. However, to make the use of these bioactive molecules feasible, optimization of their extraction, purification, and formulation is required. In the past 20 years, we have been witnessing the introduction of nanotechnology systems in cosmetic and medical device products. Their use brings several advantages, such as targeting and promoting the absorption of molecules through the skin and external mucous membranes, protecting molecules from degradation and prolonged release, among others. However, the use of this type of technology in cosmetic and medical device products raises regulatory issues that must be taken into account by manufacturers and deserve deep reflection. With this topic, the editors intend to reflect on the future perspectives of cosmetic and medical device products, taking into account not only the use of bioactive molecules obtained from residues and from biotechnological processes, but also the use of nanotechnology to improve the efficacy of the final products.
Prof. Dr. Ana Catarina Silva
Dr. Hugo Almeida
Prof. Dr. Ana Barros
Topic Editors
Keywords
- cosmetic products
- medical devices
- industrial waste
- natural compounds
- bioactive agents
- nanotechnology
- nanoparticles
Participating Journals
Journal Name | Impact Factor | CiteScore | Launched Year | First Decision (median) | APC |
---|---|---|---|---|---|
![]()
Pharmaceuticals
|
4.3 | 6.1 | 2004 | 13.9 Days | CHF 2900 |
![]()
Pharmaceutics
|
4.9 | 7.9 | 2009 | 15.5 Days | CHF 2900 |
![]()
Antioxidants
|
6.0 | 10.6 | 2012 | 16.9 Days | CHF 2900 |
![]()
Nanomaterials
|
4.4 | 8.5 | 2010 | 14.1 Days | CHF 2400 |
![]()
Journal of Functional Biomaterials
|
5.0 | 4.6 | 2010 | 16.6 Days | CHF 2700 |
![]()
Cosmetics
|
3.4 | 5.2 | 2014 | 22.3 Days | CHF 1800 |
Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.
MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:
- Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
- Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
- Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
- Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
- Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.